全文获取类型
收费全文 | 124625篇 |
免费 | 44462篇 |
国内免费 | 401篇 |
专业分类
耳鼻咽喉 | 2024篇 |
儿科学 | 5392篇 |
妇产科学 | 836篇 |
基础医学 | 26687篇 |
口腔科学 | 6793篇 |
临床医学 | 15632篇 |
内科学 | 27635篇 |
皮肤病学 | 4413篇 |
神经病学 | 18503篇 |
特种医学 | 6305篇 |
外国民族医学 | 6篇 |
外科学 | 16547篇 |
综合类 | 2153篇 |
一般理论 | 8篇 |
预防医学 | 8490篇 |
眼科学 | 1624篇 |
药学 | 10025篇 |
6篇 | |
中国医学 | 2757篇 |
肿瘤学 | 13652篇 |
出版年
2024年 | 28篇 |
2023年 | 213篇 |
2022年 | 414篇 |
2021年 | 2134篇 |
2020年 | 6555篇 |
2019年 | 11823篇 |
2018年 | 11335篇 |
2017年 | 12595篇 |
2016年 | 11791篇 |
2015年 | 11634篇 |
2014年 | 11846篇 |
2013年 | 12004篇 |
2012年 | 11117篇 |
2011年 | 11038篇 |
2010年 | 9633篇 |
2009年 | 6049篇 |
2008年 | 6554篇 |
2007年 | 4963篇 |
2006年 | 4693篇 |
2005年 | 4419篇 |
2004年 | 4258篇 |
2003年 | 3873篇 |
2002年 | 3659篇 |
2001年 | 2824篇 |
2000年 | 1525篇 |
1999年 | 394篇 |
1998年 | 297篇 |
1997年 | 261篇 |
1996年 | 219篇 |
1995年 | 162篇 |
1994年 | 131篇 |
1993年 | 136篇 |
1992年 | 106篇 |
1991年 | 115篇 |
1990年 | 90篇 |
1989年 | 87篇 |
1988年 | 81篇 |
1987年 | 73篇 |
1986年 | 78篇 |
1985年 | 73篇 |
1984年 | 39篇 |
1983年 | 28篇 |
1982年 | 23篇 |
1981年 | 32篇 |
1980年 | 15篇 |
1979年 | 14篇 |
1978年 | 23篇 |
1977年 | 6篇 |
1976年 | 13篇 |
1973年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
Syed M. Gilani Muhammad Khan Andrea Barbieri Manju L. Prasad 《Diagnostic Histopathology》2021,27(6):263-271
Anaplastic thyroid carcinoma (ATC) is an aggressive thyroid malignancy with high mortality rate. This malignancy arises in thyroid follicular cells either denovo or with an associated differentiated thyroid carcinoma component. Clinically, it usually presents as a rapidly enlarging mass, pain and locally compressive symptoms. Histopathologic variability and heterogeneity often pose diagnostic challenges, especially in scant and paucicellular specimens. This article describes the clinical, histopathologic and molecular features of ATC and also addresses the associated diagnostic limitations and challenges. 相似文献
2.
3.
4.
《Journal of vascular and interventional radiology : JVIR》2021,32(10):1449-1456
PurposeTo investigate the safety and efficacy of thyroid artery embolization (TAE) in the treatment of nodular goiter (NG).MethodsDuring a 5.5-year period, 56 consecutive patients with a NG underwent TAE. In Group A, there were 20 patients with a solitary/dominant 5–11-cm nodule, and in Group B, there were 36 patients with numerous nodules. Of the 56 patients, 47 (84%) had a retrosternal goiter and 25 had hyperthyroidism. In all patients, clinical and radiological evaluations were made at baseline and 6 months after TAE, and these parameters were statistically compared.ResultsIn 56 patients, 145 of the 146 thyroid arteries were successfully embolized. The 30-day mortality rate was 1.8%. Minor and major complications occurred in 25 and 2 patients, respectively. Six months after the TAE, the mean nodule volume was reduced from 80.2 mL to 25.0 mL, the mean thyroid volume was reduced from 147.0 mL to 62.6 mL, and the mean intrathoracic extension was reduced from 31.7 mm to 15.9 mm (P < .001). Of the 22 patients with non–Graves hyperthyroidism, 19 (86%) became euthyroid. The mean thyroid-related patient-reported outcome scores improved from 155.4 to 70.4 (P < .001). Of the 51 patients, 50 (98%) declared that they would recommend TAE to other patients with NG.ConclusionsTAE is safe and effective for the treatment of NG, with a significant volume reduction of the nodule(s) and thyroid gland. 相似文献
5.
6.
7.
8.
9.
Phoebe Hammer Kevin White Stephanie Mengden Vessy Korcheva Philipp W. Raess 《Journal of cutaneous pathology》2019,46(5):343-346
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances. 相似文献
10.
Keiko Goto Yutaka Fujiwara Takeshi Isobe Naoko Chayahara Naomi Kiyota Toru Mukohara Yukari Tsubata Takamasa Hotta Kenji Tamura Noboru Yamamoto Hironobu Minami 《Cancer science》2019,110(6):1987-1994
Although dose reduction of S‐1 is recommended for patients with impaired renal function, dose modification for such patients has not been prospectively evaluated. The aim of the present study was to investigate the pharmacokinetic parameters of 5‐fluorouracil, 5‐chloro‐2,4 dihydroxypyridine and oteracil potassium, and to review the recommended dose modification of S‐1 in patients with renal impairment. We classified patients receiving S‐1 into 4 groups according to their renal function, as measured using the Japanese estimated glomerular filtration rate (eGFR) equation. The daily S‐1 dose was adjusted based on the patient's eGFR and body surface area. Blood samples were collected for pharmacokinetic analysis. A total of 33 patients were enrolled and classified into 4 groups as follows: 10 patients in cohort 1 (eGFR ≥ 80 mL/min/1.73 m2), 10 patients in cohort 2 (eGFR = 50‐79 mL/min/1.73 m2), 10 patients in cohort 3 (eGFR = 30‐49 mL/min/1.73 m2), and 3 patients in cohort 4 (eGFR < 30 mL/min/1.73 m2). Those in cohorts 3 and 4 treated with an adjusted dose of S‐1 showed a similar area under the curve for 5‐fluorouracil (941.9 ± 275.6 and 1043.5 ± 224.8 ng/mL, respectively) compared with cohort 2 (1034.9 ± 414.3 ng/mL). Notably, while there was a statistically significant difference between cohort 1 (689.6 ± 208.8 ng/mL) and 2 (P = 0.0474) treated with an equal dose of S‐1, there was no significant difference observed in the toxicity profiles of the cohorts. In conclusion, dose adjustment of S‐1 in patients with impaired renal function using eGFR is appropriate and safe. 相似文献